118 related articles for article (PubMed ID: 15154643)
21. [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer].
Sheng WW; Zhou JP; Kong FM; Li YJ; Dong M
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):728-31. PubMed ID: 23157907
[TBL] [Abstract][Full Text] [Related]
22. Histopathological study of invasive ductal carcinoma (IDC) of the pancreas without associated cancerous occlusion of the main pancreatic duct.
Naito Y; Suda K; Nobukawa B; Kinoshita H; Kojiro M
J Hepatobiliary Pancreat Surg; 2006; 13(6):556-61. PubMed ID: 17139431
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas.
Nio Y; Iguchi C; Yamasawa K; Sasaki S; Takamura M; Toga T; Dong M; Itakura M; Tamura K
Pancreas; 2001 Apr; 22(3):230-9. PubMed ID: 11291923
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
[TBL] [Abstract][Full Text] [Related]
25. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
27. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.
Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y
Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336
[TBL] [Abstract][Full Text] [Related]
29. DPC4/Smad4 protein is highly expressed in intraductal papillary-mucinous neoplasms.
Kume K; Suda K; Nobukawa B; Sonoue H
Histopathology; 2006 Jun; 48(7):874-6. PubMed ID: 16722941
[No Abstract] [Full Text] [Related]
30. [Comparison of pBcl-2 and pBax expression in primary invasive ductal pancreatic cancer between Chinese and Japanese patients].
Zhou JP; Dong M; Nio Y; Kong FM; Zheng XY; Guo KJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):611-4. PubMed ID: 16274043
[TBL] [Abstract][Full Text] [Related]
31. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer].
Hua ZM; Li Z; Lou DL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930
[TBL] [Abstract][Full Text] [Related]
32. [The effects of transferring DPC4-adenovirus on pancreatic adenocarcinoma cells].
Feng XL; Zhang ZD; Tian L; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):607-11. PubMed ID: 15460398
[TBL] [Abstract][Full Text] [Related]
33. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.
Liu F
Clin Cancer Res; 2001 Dec; 7(12):3853-6. PubMed ID: 11751474
[No Abstract] [Full Text] [Related]
34. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
[TBL] [Abstract][Full Text] [Related]
35. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
[TBL] [Abstract][Full Text] [Related]
36. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats].
Liang S; Yang ZL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598
[TBL] [Abstract][Full Text] [Related]
37. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
39. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
40. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
